» Articles » PMID: 15331316

Mechanisms and Management of Hypertensive Heart Disease: from Left Ventricular Hypertrophy to Heart Failure

Overview
Specialty General Medicine
Date 2004 Aug 28
PMID 15331316
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertensive heart disease (HHD) is a spectrum of abnormalities that represents the accumulation of a lifetime of functional and structural adaptations to increased blood pressure load. Left ventricular hypertrophy (LVH), increasing vascular and ventricular stiffness,and diastolic dysfunction are prominent intermediate features of this syndrome that operate in parallel with ischemic heart disease and ultimately cause heart failure (HF) if inadequately treated. Outcomes in HHD and HF are improved by antihypertensive drugs at any stage of the condition. This review describes an integrated model of the natural history, pathogenesis, and drug treatment of hypertensive heart disease that is consistent with the recommendations of the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, including an important modification to the HF guideline published by the American College of Cardiology and the American Heart Association that includes LVH and diastolic dysfunction as treatable conditions within the HHD-HF continuum.

Citing Articles

Cardiotrophin-1 in Asymptomatic Hypertensive Patients With Mild Diastolic Dysfunction: Potential Prognostic Value in Early Stages of Hypertensive Heart Disease.

Vlahodimitris I, Karangelis D, Moschaki M, Moyssakis I, Christodoulou K, Perrea D Cureus. 2023; 15(10):e46516.

PMID: 37927758 PMC: 10625173. DOI: 10.7759/cureus.46516.


Correlation of systolic and diastolic blood pressure with echocardiographic phenotypes of cardiac structure and function from three German population-based studies.

Nikorowitsch J, Bei der Kellen R, Haack A, Magnussen C, Prochaska J, Wild P Sci Rep. 2023; 13(1):14525.

PMID: 37666935 PMC: 10477248. DOI: 10.1038/s41598-023-41571-x.


Ameliorative effect of mussel-derived ACE inhibitory peptides on spontaneous hypertension rats.

You Q, Sun X, Chen J, Yu J, Wei Y Eur J Nutr. 2023; 62(7):3097-3111.

PMID: 37505286 DOI: 10.1007/s00394-023-03222-9.


Hypertensive Heart Disease: A Narrative Review Series-Part 1: Pathophysiology and Microstructural Changes.

Nemtsova V, Vischer A, Burkard T J Clin Med. 2023; 12(7).

PMID: 37048689 PMC: 10094934. DOI: 10.3390/jcm12072606.


Blocking VCAM-1 ameliorates hypertensive cardiac remodeling by impeding macrophage infiltration.

Qiu Z, Yu W, Bai J, Lin Q Front Pharmacol. 2022; 13:1058268.

PMID: 36467095 PMC: 9713306. DOI: 10.3389/fphar.2022.1058268.